Tilray Brands just posted record numbers for Q2. Is the stock a buy?
Now, it’s worth noting Stock Advisor’s total average return is 955 % — a market-crushing outperformance compared to 196% for the S&P 500. Don’t miss the latest top 10 list, available with Stock …
Aurora Cannabis Inc. stock falls Tuesday, still outperforms market
This was the stock’s third consecutive day of losses.
This Beaten-Down Stock Just Posted Record Revenue. Is It Finally Time to Buy?
So far, the company has been unable to do so and has partly relied on acquisitions during the past five years to increase its market share. Further, cannabis remains illegal at the federal level, even …
Will pot stocks rebound in 2026?
Beacon Securities analyst Russell Stanley said in a January 15 industry update that the post-correction recovery in U.S. cannabis equities remains intact …
Should You Buy This Cannabis Stock While It’s Under $2?
Canopy Growth › Buying a stock for a mere $2 may sound cheap on the surface, but that’s only the case if there are good reasons to expect it to increase in value significantly. Take Canopy Growth …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio
Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare …
Tilray Brands just posted record numbers for Q2. Is the stock a buy?
Now, it’s worth noting Stock Advisor’s total average return is 955 % — a market-crushing outperformance compared to 196% for the S&P 500. Don’t miss the latest top 10 list, available with Stock …
Aurora Cannabis Inc. stock falls Tuesday, still outperforms market
This was the stock’s third consecutive day of losses.
This Beaten-Down Stock Just Posted Record Revenue. Is It Finally Time to Buy?
So far, the company has been unable to do so and has partly relied on acquisitions during the past five years to increase its market share. Further, cannabis remains illegal at the federal level, even …
Tilray Stock Couldn’t Sustain Its Trump Gains. How Cannabis Earnings Could Help.
When speculation broke out that President Donald Trump could move to reschedule marijuana as a Schedule III drug before the end of 2025, cannabis stocks soared. Those gains were short-lived.
The 3 Best Cannabis Stocks to Buy for 2026
These three cannabis stocks mix regulatory optionality, steady operators, and biotech risk as investors position for 2026 reform tailwinds.
Trump’s Marijuana Order Is Lighting Up This Cannabis ETF: Momentum Score Spikes
The AdvisorShares Pure U.S. Cannabis ETF (NYSE: MSOS), which invests in U.S. marijuana and hemp stocks, is seeing a surge in Momentum in Benzinga’s Edge Stock Rankings, as Washington starts warming up …
Should You Buy ACB Stock After Marijuana Reclassification Order?
Aurora Cannabis faces uneven gains from marijuana reclassification as medical cannabis drives growth, while weak consumer sales affect optimism.
The cannabis stock correction is over, this analyst says
U.S. cannabis stocks appear to have completed their post-Executive Order pullback, says Beacon Securities analyst Russell Stanley …
Recent Comments